Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of the present study is to evaluate the effectiveness of daily consumption of a Combination of Plant Extracts (BSL_EP027) on the incidence of respiratory infection symptoms and their duration in older healthy volunteers living in a nursing home.
A prevalence of deficient immune state is estimated at 44% of the world's population, a figure that rises in the senior population group.
Traditionally, protection against infection and improvement of the immune response has been addressed through the use of plant extracts. An effective immune response involves the action of both innate and specific responses and the perfect coordination between both. Natural strategies that can activate both types of immune response can lead to more effective treatments.
Our hypothesis is that the different effects of the combination of several plant extracts can lead to a synergy that generates a more effective product in the prevention of respiratory infections, especially in susceptible populations such as the elderly.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Combination of plant extracts (BSL_EP027) | Experimental | Volunteers will dissolve in water a sachet per day with the Combination of plant extracts (BSL_EP027), and maltodextrin. |
|
| Placebo | Placebo Comparator | Volunteers will dissolve in water a sachet per day with maltodextrin. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Combination of plant extracts (BSL_EP027) | Combination Product | Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life. |
| Measure | Description | Time Frame |
|---|---|---|
| Respiratory infection symptoms | Incidence of respiratory infection symptoms (fiber, cough, rinitis, headache, sore throat, bone and/or muscle pain, fatigue/exhaustion, nausea and/or vomiting, lack of appetite and /or trouble for sleeping) | 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of the respiratory infection symptoms | Duration of the respiratory infection symptoms (days) | 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Type of Medication for the respiratory infection symptoms | Type of medication for the respiratory infection symptoms | 16 weeks |
| Dose of the Medication for the respiratory infection symptoms | Dose of the medical treatment for the respiratory infection symptoms |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carlos Gracián, MD | Doctor of the Claret Nursing Home (Granada, Spain) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Claret Nursing home | Granada | 18011 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Combination Product | Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life. |
|
| 16 weeks |
| Duration of the medical treatment for the respiratory infection symptoms | Duration of the medical treatment for the respiratory infection symptoms | 16 weeks |